1Tanaka M,Nyce JW.Respirable antisense oligonucleotides:a new drug class for respiratory disease[J].Respir Res,2001,2(1):5-9.
2Nyce JW,Metzger WJ.DNA antisense therapy for asthma animal model[J].Nature,1997,385(6618):721-725.
3Ali S,Leonard SA,Kukoly CA,et al.Absorption,distribution,metabolism,and excrefon of a respirable antiseme oligonucleofde for asthma[J].Am J Respir Crit Care Med,2001,163(4):989-993.
4Simon HU,Yousefi S,Schranz C,et al.Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia[J].J Immunol,1997,158(8):3902-3908.
5Karras JG,McGraw K,Mckay RA,et al.Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiiveness by an IL-5 antisense oligonucleotide in mouse models of asthma[J].J Immunol,2000,164(10):5409-5415.
6Kotsimbos AT,Hamid Q.IL-5 and IL-5 receptor in asthma[J].Mem Inst Oswaldo Cruz,1997,92(Suppl 2):75-91.
7Karras JG,McKay PA,Deann NM,et al.Deletion of indibidual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing[J].Mol Pharmacol,2000,58(2):380-387.
8Molet S,Ramos-Barbon D,Martin JG,et al.Adoptively transferred late allergic response is inhibited by IL-4,but not IL-5,antisense oligonucleotide[J].J Allergy Clin Immunol,1999,104(1):205-214.
9Allakhverdi Z,Allam M,Renzi PM,et al.Ihibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3,IL-5,GM-CSF receptors in a rat model of allergic asthma[J].Am J Respir Crit Care Med,2002,165(7):1015-1021.
10Finotto S,Buerke M,Lingnau K,et al.Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand,stem cell factor,suppresses airway inflammation and IL-4 production in a murine model of asthma[J].J Allergy Clin Immunol,2001,107(2):279-286.
二级参考文献12
1Christman JW;Blackwell TS.The role of nuclear factor-κB in pulmonary disease[J],2000(5).
2Yamamoto Y;Gaynor RB.Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer[J],2001.
3Kawamura I;Morishita R;Tsujimoto S.Intravenous injection of oligodeoxynucleotides to the NF-κB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice[J],2001(08).
4Hart LA;Krishnan VL;Adcock IM.Activation and localization of transcription factor,nuclear factor-κB,in asthma[J],1999(5 Pt 1).
5Paul HL.Activators and target gene of Rel/NF-κB transcription factors[J],1999.
6Morishita R;Sugimoto T;Aoki M.In vivo transfection of cis element 'decoy' against NF-κB binding site prevents myocardial infarction[J],1997.
7Yokoseke O;Suzuki J;Kitabayashi H.Cis element decoy against NF-κB attenuates development of experimental autoimmune myocarditis in rats[J],2001(10).
8Templin MV;Levin AA;Graham MJ.Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotide following inhalation delivery to lung in mice,2000.
2Chen EH ,Cadina M,Galon J ,et al. Not just another meeting: the coming of age of JAKs and STATs[J]. Immunol Today, 1998,19(8) :338- 341.
3Andrews RP, Ericksen MB, Cunningham CM, et al. Analysis of the life cycle of star6. Continuous cycling of STAT8 is required for IL-4 signaling[J]. J Biol Chem, 2002,277 (39) : 36583-36569.
4Look DC. Pelfetier MR, Holtzman MJ. Selective interaction of a subset of interferon gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial eells[J]. J Biol Chem,1994,269(12) :8952-8958.
5Henderson WR Jr, Lewis DB, Albert RK, et al. The importance of leukolrienes in airway inflammation in a mouse model of asthma[J]. J Exp Med, 1996,184(4) : 1483-1494.
6Hosoya K, Satoh T. Yamamoto Y, et al. Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis[J]. Allergy, 2011,66( 1 ): 124-131.
7Ahmad MZ, Akhter S, Mallik N, et al. Application of decoy oligonueleotides as novel therapeutic strategy:a contemporary overview[J]. Curr Drug Discov Teehnol, 2013,10 ( 1 ) : 71-84.
8Sumi K,Yokozeki H,Wu MH,et ai. In vivo transfection of a cis element "decoy' against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity[J]. Gene Ther, 2004,11 (24) : 1763-1771.
9Yokozeki H. A Decoy Oligodeoxynucleotides therapy for allergic skin diseases [J]. Nihon Rinsho Meneki Gakkai Kaishi, 2012,35 (2) : 107-111.
10Sun C, Hu Y, l.iu X, et al. Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion,arrest of cell cycle, and induction of apoptosis[J]. Cancer (;enet Cytogenet, 2006,165 ( 1 ) : 9-19.
